CClinicalTrials.gg
Status unknownNCT03636009Updated Oct 19, 2018

Concurrent Treatment for Patients With Cervical Radiculopathy

An interventional study of concurrent traction and neuromobilization technique and sequential traction and neuromobilization technique in Spinal Nerve Root Disorder Nos, sponsored by University of Indianapolis. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-19.

Sponsored by University of Indianapolis · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the effectiveness of two treatment interventions in patients with cervical radiculopathy. One group will receive a concurrent approach using traction and neuromobilizations. The other group will receive the sequential approach of traction and neuromobilizations

Read the detailed description

Physical therapists routinely use cervical traction and manual therapy in patients with cervical radiculopathy. The standard of care is a sequential approach in which the patients receive interventions successively. This study will provide the standard of care approach for one group while the other group receives the concurrent approach in which the patient will have neuromobilizations while they are receiving mechanical traction. Both groups will also receive exercise and manual therapy to the cervical and thoracic spine.

02

Conditions studied

  • Spinal Nerve Root Disorder Nos

Browse trials for

Keywords

  • cervical radiculopathy
  • neck pain
  • neuromobilizations
03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 141 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 376 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

University of Indianapolis is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants that test positive on at least 3 out of 4 special tests.
  • Participants will score at least 10 on the Neck Disability Index
  • Participants will score at least 2 on the numeric pain rating scale

Exclusion criteria

Exclusion Criteria:

  • Do not test positive on at least 3 of 4 special tests.
  • Signs of cervical trauma
  • Cervical myelopathy
  • Active pregnancy
  • Medical red flags (fracture, tumor, long term steroid use, rheumatoid arthritis, and osteoporosis)
  • Evidence of vascular compromise
  • Cervical spine surgery
  • Recent injections in the past six weeks
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Concurrent traction

    Concurrent traction and neuromobilization technique at each scheduled session Active exercise program (4-5 exercises) at each session Manual therapy to cervical and thoracic spine at each session

    Other: concurrent traction and neuromobilization technique · Other: active exercise program · Other: manual therapy to cervical and thoracic spine

  • Active comparator
    Sequential traction

    Sequential traction and neuromobilization technique at each scheduled session Active exercise program (4-5 exercises) at each session Manual therapy to cervical and thoracic spine at each session

    Other: sequential traction and neuromobilization technique · Other: active exercise program · Other: manual therapy to cervical and thoracic spine

Interventions

  • Otherconcurrent traction and neuromobilization technique

    participant will be on a mechanical traction machine with an on:off cycle. During the on cycle, the primary researcher will be performing a neuromobilization technique on the symptomatic arm. Patients will also receive exercise and manual therapy

    Also known as: Concurrent traction, Neurmobilization technique

  • Othersequential traction and neuromobilization technique

    Participants will receive neuromobilzation techniques followed by supine cervical traction

    Also known as: Sequential traction

  • Otheractive exercise program

    Participants will have 4-5 exercises to perform at each session

  • Othermanual therapy to cervical and thoracic spine

    Lateral glides to cervical spine and thoracic manipulations

06

What researchers measure

Primary outcomes

  1. changes in pain

    Measured using the Numeric pain rating scale. Minimum score is 0 and maximum score is 10. 0 describes no pain and 10 describes worst pain imaginable.

    Time frame: after 4 weeks of intervention

  2. changes in function

    Measured using the Neck Disability Index. The Neck Disability Index has a minimum score of 0 and maximum score of 50. It is typically expressed as a percentage by multiplying the score by 2. Higher scores represent greater disability.

    Time frame: After 4 weeks of intervention

Secondary outcomes

  1. Difference in treatment time between the groups

    average minutes in treatment in each group

    Time frame: 4 weeks of intervention

07

Study locations

1 of 1 sites recruiting
  • Michiana Orthopaedics and Sports Physical Therapy
    Mishawaka, Indiana 46544, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03636009
Lead sponsor
University of Indianapolis
Responsible party
James W. Bellew (Professor, University of Indianapolis) — Principal investigator
First posted
Aug 17, 2018
Start date
Oct 1, 2018
Primary completion
Jul 31, 2019 (estimated)
Completion
Sep 30, 2019 (estimated)
Last update
Oct 19, 2018

Study contacts

Patrick Christianson
Contact
christiansonpj@uindy.edu
574-485-6082
James Bellew, EdD
Contact
bellew@uindy.edu
317-788-3522
James Bellew, EdD
principal investigator · University of Indianapolis

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion